Personalized medicine AI uses machine learning to tailor medical treatment to individual patient characteristics — analyzing genomic data, biomarkers, medical history, and lifestyle factors to predict treatment response, optimize drug selection and dosing, and identify the right therapy for each patient, moving from one-size-fits-all to precision healthcare.

What Is Personalized Medicine AI?

• Definition: AI-driven individualization of medical treatment.
• Input: Genomics, biomarkers, clinical data, demographics, lifestyle.
• Output: Treatment recommendations, drug selection, dosing, risk predictions.
• Goal: Right treatment, right patient, right dose, right time.

Why Personalized Medicine?

• Treatment Variability: Same drug works for only 30-60% of patients.
• Adverse Reactions: 2M serious adverse drug reactions annually in US.
• Cancer Heterogeneity: Each tumor genetically unique, needs tailored therapy.
• Cost: Avoid expensive ineffective treatments, reduce trial-and-error.
• Outcomes: Personalized approaches improve response rates 2-3×.

Key Applications

Pharmacogenomics:

• Task: Predict drug response based on genetic variants.
• Example: CYP2C19 variants affect clopidogrel (blood thinner) effectiveness.
• Use: Adjust drug choice or dose based on genetics.
• Impact: Reduce adverse reactions, improve efficacy.

Cancer Treatment Selection:

• Task: Match cancer patients to targeted therapies based on tumor genomics.
• Method: Sequence tumor, identify actionable mutations.
• Example: EGFR mutations → EGFR inhibitors for lung cancer.
• Benefit: Higher response rates, avoid ineffective chemotherapy.

Disease Risk Prediction:

• Task: Calculate individual risk for diseases based on genetics + lifestyle.
• Example: Polygenic risk scores for heart disease, diabetes, Alzheimer's.
• Use: Targeted screening, preventive interventions.

Treatment Response Prediction:

• Task: Predict which patients will respond to specific treatments.
• Data: Biomarkers, imaging, clinical features, prior treatments.
• Example: Predict immunotherapy response in cancer patients.

Tools & Platforms: Foundation Medicine, Tempus, 23andMe, Color Genomics.